Bulk Manufacturer of Controlled Substances Application: Noramco, Inc., 41055-41056 [2017-18315]
Download as PDF
<![CDATA[
41055
Federal Register / Vol. 82, No. 166 / Tuesday, August 29, 2017 / Notices
respect to the promulgation and
implementation of 21 CFR part 1301,
incident to the registration of
manufacturers, distributors, dispensers,
importers, and exporters of controlled
substances (other than final orders in
connection with suspension, denial, or
revocation of registration) has been
redelegated to the Assistant
Administrator of the DEA Diversion
Control Division (‘‘Assistant
Administrator’’) pursuant to section 7 of
28 CFR part 0, appendix to subpart R.
In accordance with 21 CFR
1301.34(a), this is notice that on January
18, 2017, Stepan Company, Natural
Products Dept., 100 W. Hunter Avenue,
Maywood, New Jersey 07607 applied to
be registered as an importer of coca
leaves (9040), a basic class of controlled
substance listed in schedule II.
The company plans to import the
listed controlled substance in bulk for
the manufacture of controlled substance
for distribution to its customers.
Dated: August 21, 2017.
Demetra Ashley,
Acting Assistant Administrator.
[FR Doc. 2017–18313 Filed 8–28–17; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–392]
Importer of Controlled Substances
Application: Cambrex Charles City
ACTION:
Notice of application.
Registered bulk manufacturers of
the affected basic classes, and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration in
accordance with 21 CFR 1301.34(a) on
or before September 28, 2017. Such
persons may also file a written request
for a hearing on the application
pursuant to 21 CFR 1301.43 on or before
September 28, 2017.
ADDRESSES: Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DRW, 8701
Morrissette Drive, Springfield, Virginia
22152. All requests for hearing must be
sent to: Drug Enforcement
Administration, Attn: Administrator,
8701 Morrissette Drive, Springfield,
Virginia 22152. All requests for hearing
should also be sent to: (1) Drug
Enforcement Administration, Attn:
Hearing Clerk/LJ, 8701 Morrissette
Drive, Springfield, Virginia 22152; and
DATES:
(2) Drug Enforcement Administration,
Attn: DEA Federal Register
Representative/DRW, 8701 Morrissette
Drive, Springfield, Virginia 22152.
Comments and request for hearing on
applications to import narcotic raw
material are not appropriate. 72 FR 3417
(January 25, 2007).
SUPPLEMENTARY INFORMATION: The
Attorney General has delegated his
authority under the Controlled
Substances Act to the Administrator of
the Drug Enforcement Administration
(DEA), 28 CFR 0.100(b). Authority to
exercise all necessary functions with
respect to the promulgation and
implementation of 21 CFR part 1301,
incident to the registration of
manufacturers, distributors, dispensers,
importers, and exporters of controlled
substances (other than final orders in
connection with suspension, denial, or
revocation of registration) has been
redelegated to the Assistant
Administrator of the DEA Office of
Diversion Control (‘‘Assistant
Administrator’’) pursuant to section 7 of
28 CFR part 0, appendix to subpart R.
In accordance with 21 CFR
1301.34(a), this is notice that on June
12, 2017, Cambrex Charles City, 1205
11th Street, Charles City, Iowa 50616
applied to be registered as an importer
of the following basic classes of
controlled substances:
Controlled substance
Drug code
4-Anilino-N-phenethyl-4-piperidine (ANPP) .....................................................................................................................
Phenylacetone .................................................................................................................................................................
Coca Leaves ....................................................................................................................................................................
Opium, raw ......................................................................................................................................................................
Poppy Straw Concentrate ...............................................................................................................................................
The company plans to import the
listed controlled substances for internal
use, and to manufacture bulk
intermediates for sale to its customers.
Dated: August 21, 2017.
Demetra Ashley,
Acting Assistant Administrator.
[FR Doc. 2017–18314 Filed 8–28–17; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
sradovich on DSK3GMQ082PROD with NOTICES
Drug Enforcement Administration
[Docket No. DEA–392]
Bulk Manufacturer of Controlled
Substances Application: Noramco, Inc.
ACTION:
Notice of application.
Registered bulk manufacturers of
the affected basic classes, and
DATES:
VerDate Sep<11>2014
18:45 Aug 28, 2017
Jkt 241001
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration in
accordance with 21 CFR 1301.33(a) on
or before October 30, 2017.
ADDRESSES: Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DRW, 8701
Morrissette Drive, Springfield, Virginia
22152.
SUPPLEMENTARY INFORMATION: The
Attorney General has delegated his
authority under the Controlled
Substances Act to the Administrator of
the Drug Enforcement Administration
(DEA), 28 CFR 0.100(b). Authority to
exercise all necessary functions with
respect to the promulgation and
implementation of 21 CFR part 1301,
incident to the registration of
manufacturers, distributors, dispensers,
importers, and exporters of controlled
PO 00000
Frm 00074
Fmt 4703
Sfmt 4703
8333
8501
9040
9600
9670
Schedule
II
II
II
II
II
substances (other than final orders in
connection with suspension, denial, or
revocation of registration) has been
redelegated to the Assistant
Administrator of the DEA Diversion
Control Division (‘‘Assistant
Administrator’’) pursuant to section 7 of
28 CFR part 0, appendix to subpart R.
In accordance with 21 CFR
1301.33(a), this is notice that on July 6,
2017, Noramco, Inc., 500 Swedes
Landing Road, Wilmington, Delaware
19801–4417 applied to be registered as
a bulk manufacturer of the following
basic classes of controlled substances:
Controlled
substance
Marihuana .....................
Tetrahydrocannabinols
Codeine-N-oxide ...........
Dihydromorphine ..........
Hydromorphinol ............
E:\FR\FM\29AUN1.SGM
29AUN1
Drug
code
7360
7370
9053
9145
9301
Schedule
I
I
I
I
I
41056
Federal Register / Vol. 82, No. 166 / Tuesday, August 29, 2017 / Notices
Controlled
substance
Morphine-N-oxide .........
Amphetamine ...............
Methylphenidate ...........
Nabilone .......................
Phenylacetone ..............
Codeine ........................
Dihydrocodeine .............
Oxycodone ...................
Hydromorphone ............
Hydrocodone ................
Morphine .......................
Oripavine ......................
Thebaine .......................
Opium extracts .............
Opium fluid extract .......
Opium tincture ..............
Opium, powdered .........
Opium, granulated ........
Oxymorphone ...............
Noroxymorphone ..........
Tapentadol ....................
Drug
code
Schedule
9307
1100
1724
7379
8501
9050
9120
9143
9150
9193
9300
9330
9333
9610
9620
9630
9639
9640
9652
9668
9780
I
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
The company plans to manufacture
the above-listed controlled substances
in bulk for distribution to its customers.
In reference to drug code 7360, the
company plans to manufacture a
synthetic version of cannabidiol in bulk
for sale to its customers, who are final
dosage form manufacturers. No other
activity for this drug code is authorized
for this registration.
Dated: August 21, 2017.
Demetra Ashley,
Acting Assistant Administrator.
[FR Doc. 2017–18315 Filed 8–28–17; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
[OMB Number 1125–0005]
Agency Information Collection
Activities; Proposed Collection;
Comments Requested; Request To Be
Included on the List of Pro Bono Legal
Service Providers for Individuals in
Immigration Proceedings (Form EOIR–
56)
Executive Office for
Immigration Review, Department of
Justice.
ACTION: 30-day Notice.
sradovich on DSK3GMQ082PROD with NOTICES
AGENCY:
SUMMARY: The Department of Justice
(DOJ), Executive Office for Immigration
Review (EOIR), will be submitting the
following information collection request
to the Office of Management and Budget
(OMB) for review and approval in
accordance with the Paperwork
Reduction Act of 1995. The proposed
information collection was previously
published in the Federal Register on
June 26, 2017, allowing for a 60-day
comment period.
VerDate Sep<11>2014
18:45 Aug 28, 2017
Jkt 241001
Comments are encouraged and
will be accepted for additional days
until September 28, 2017.
FOR FURTHER INFORMATION CONTACT: If
you have comments especially on the
estimated public burden or associated
response time, suggestions, or need a
copy of the proposed information
collection instrument with instructions
or additional information, please
contact Jean King, General Counsel,
USDOJ–EOIR–OGC, Suite 2600, 5107
Leesburg Pike, Falls Church, Virginia,
20530; telephone: (703) 305–0470.
Written comments and/or suggestions
can also be sent to the Office of
Management and Budget, Office of
Information and Regulatory Affairs,
Attention Department of Justice Desk
Officer, Washington, DC 20503 or sent
to OIRA_submissions@omb.eop.gov.
SUPPLEMENTARY INFORMATION: Written
comments and suggestions from the
public and affected agencies concerning
the proposed collection of information
are encouraged. Your comments should
address one or more of the following
four points:
—Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
—Evaluate the accuracy of the agency’s
estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
—Enhance the quality, utility, and
clarity of the information to be
collected; and/or
—Minimize the burden of the collection
of information on those who are to
respond, including through the use of
appropriate automated, electronic,
mechanical, or other technological
collection techniques or other forms
of information technology, e.g.,
permitting electronic submission of
responses.
Overview of this information
collection:
1 Type of Information Collection:
Revision of a currently approved
collection.
2 The Title of the Form/Collection:
Request to be Included on the List of Pro
Bono Legal Service Providers for
Individuals in Immigration Proceedings.
3 The agency form number: EOIR–56
(OMB #1125–0015).
4 Affected public who will be asked
or required to respond, as well as a brief
abstract:
Primary: Legal service providers
seeking to be included on the List of Pro
Bono Legal Service Providers (‘‘List’’), a
DATES:
PO 00000
Frm 00075
Fmt 4703
Sfmt 4703
list of persons who have indicated their
availability to represent aliens on a pro
bono basis. Abstract: EOIR seeks to
replace the current paper version of the
EOIR Forms-56, with an electronic
system to make an initial application
and apply for continued participation in
the List. Form EOIR–56 will be
mandatory, and is intended to elicit, in
a uniform manner, all of the required
information for EOIR to determine
whether an applicant meets the
eligibility requirements for inclusion on
the List.
5 An estimate of the total number of
respondents and the amount of time
estimated for an average respondent to
respond: It is estimated that 161
respondents will complete each form
within approximately 30 minutes.
6 An estimate of the total public
burden (in hours) associated with the
collection: 80.5 annual burden hours.
If additional information is required
contact: Jake Bishop-Green, Acting
Department Clearance Officer, United
States Department of Justice, Justice
Management Division, Policy and
Planning Staff, Two Constitution
Square, 145 N Street NE., 3E.405B,
Washington, DC 20530.
Dated: August 24, 2017.
Jake Bishop-Green,
Acting Department Clearance Officer for PRA,
U.S. Department of Justice.
[FR Doc. 2017–18287 Filed 8–28–17; 8:45 am]
BILLING CODE 4410–30–P
DEPARTMENT OF JUSTICE
[OMB Number 1121–0220]
Agency Information Collection
Activities; Proposed New e-Collection;
Bureau of Justice Assistance
Application Form: Public Safety
Officers’ Benefits (PSOB) Program
Applications Package
Bureau of Justice Assistance,
Department of Justice.
ACTION: 30-day notice.
AGENCY:
SUMMARY: The Department of Justice,
Office of Justice Programs, Bureau of
Justice Assistance, will be submitting
the following information collection
request for review and clearance in
accordance with the Paperwork
Reduction Act of 1995.
DATES: Comments are encouraged and
will be accepted for 30 days until
September 28, 2017.
FOR FURTHER INFORMATION CONTACT: If
you have additional comments
especially on the estimated public
burden or associated response time,
suggestions, or need a copy of the
E:\FR\FM\29AUN1.SGM
29AUN1
]]>Agencies
[Federal Register Volume 82, Number 166 (Tuesday, August 29, 2017)]
[Notices]
[Pages 41055-41056]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-18315]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-392]
Bulk Manufacturer of Controlled Substances Application: Noramco,
Inc.
ACTION: Notice of application.
-----------------------------------------------------------------------
DATES: Registered bulk manufacturers of the affected basic classes, and
applicants therefore, may file written comments on or objections to the
issuance of the proposed registration in accordance with 21 CFR
1301.33(a) on or before October 30, 2017.
ADDRESSES: Written comments should be sent to: Drug Enforcement
Administration, Attention: DEA Federal Register Representative/DRW,
8701 Morrissette Drive, Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION: The Attorney General has delegated his
authority under the Controlled Substances Act to the Administrator of
the Drug Enforcement Administration (DEA), 28 CFR 0.100(b). Authority
to exercise all necessary functions with respect to the promulgation
and implementation of 21 CFR part 1301, incident to the registration of
manufacturers, distributors, dispensers, importers, and exporters of
controlled substances (other than final orders in connection with
suspension, denial, or revocation of registration) has been redelegated
to the Assistant Administrator of the DEA Diversion Control Division
(``Assistant Administrator'') pursuant to section 7 of 28 CFR part 0,
appendix to subpart R.
In accordance with 21 CFR 1301.33(a), this is notice that on July
6, 2017, Noramco, Inc., 500 Swedes Landing Road, Wilmington, Delaware
19801-4417 applied to be registered as a bulk manufacturer of the
following basic classes of controlled substances:
------------------------------------------------------------------------
Drug
Controlled substance code Schedule
------------------------------------------------------------------------
Marihuana.............................. 7360 I
Tetrahydrocannabinols.................. 7370 I
Codeine-N-oxide........................ 9053 I
Dihydromorphine........................ 9145 I
Hydromorphinol......................... 9301 I
[[Page 41056]]
Morphine-N-oxide....................... 9307 I
Amphetamine............................ 1100 II
Methylphenidate........................ 1724 II
Nabilone............................... 7379 II
Phenylacetone.......................... 8501 II
Codeine................................ 9050 II
Dihydrocodeine......................... 9120 II
Oxycodone.............................. 9143 II
Hydromorphone.......................... 9150 II
Hydrocodone............................ 9193 II
Morphine............................... 9300 II
Oripavine.............................. 9330 II
Thebaine............................... 9333 II
Opium extracts......................... 9610 II
Opium fluid extract.................... 9620 II
Opium tincture......................... 9630 II
Opium, powdered........................ 9639 II
Opium, granulated...................... 9640 II
Oxymorphone............................ 9652 II
Noroxymorphone......................... 9668 II
Tapentadol............................. 9780 II
------------------------------------------------------------------------
The company plans to manufacture the above-listed controlled
substances in bulk for distribution to its customers. In reference to
drug code 7360, the company plans to manufacture a synthetic version of
cannabidiol in bulk for sale to its customers, who are final dosage
form manufacturers. No other activity for this drug code is authorized
for this registration.
Dated: August 21, 2017.
Demetra Ashley,
Acting Assistant Administrator.
[FR Doc. 2017-18315 Filed 8-28-17; 8:45 am]
BILLING CODE 4410-09-P
